Program Committee

Say “hello” to this year’s Program Committee!  ISPOR is excited to work with an amazing group of talented and passionate members dedicated to curating a robust slate of sessions and building an impactful program. It’s through their collaboration with ISPOR that we can deliver a meaningful experience to our attendees. 

Co-Chairs

Higashi
Mitch Higashi, PhD
Senior Vice President, HEOR, Sema4, Princeton, NJ, USA
Roberts
Samantha Roberts, DPhil, MBA
Chief Executive, National Institute of Health and Care Excellence (NICE), London, England, UK
Schneeweiss
Sebastian Schneeweiss, MD, ScD
Professor of Medicine and Epidemiology at Harvard Medical School and Chief of the Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA

Members

Blythe Adamson, PhD, MPH
Senior Quantitative Scientist, Flatiron Health, New York, NY, USA

 

Tamás Ágh, MD, PhD, MSc
Principal Researcher, Syreon Research Institute, Pecs, Hungary

Suliman Alghnam, PhD
Head of Population Health, King Abdulah International Medical Research Center, Riyadh, Saudi Arabia

Bill Byrom, PhD
Vice President, Product Intelligence and Positioning, Signant Health, London, England, UK

Jon Campbell, PhD, MS
Senior Vice President for Health Economics, ICER, Boston, MA, USA

Bruce Crawford, MA, MPH
Vice President, Real World & Late Phase, APAC, Syneos Health, Tokyo, Japan

Gregory Daniel, MPH, RPh, PhD
Global Head of Public Policy, Global Corporate Affairs, Eli Lilly and Company, Washington, DC, USA

Ratna Devi, MBA
CEO and Co-founder, DakshamA Health and Education, Board Member, International Alliance of Patients’ Organizations, New Delhi, India

Vijay S. Gc, MPH, PhD
Research Fellow, Centre for Health Economics, University of York, York, England, UK

Juan Marcos Gonzalez, PhD
Assistant Professor, Department of Population Health Sciences, Duke University, Durham, NC, USA

Michael Grabner, PhD
Principal Scientist, HealthCore, Inc., Wilmington, DE, USA

Lisa Hess, PhD
Senior Research Advisor, Eli Lilly and Company, Indianapolis, IN, USA

Nicholas Latimer, BSc, MSc, PhD
Reader in Health Economics, ScHARR - University of Sheffield, Sheffield, England, UK

Vittorio Maio, PharmD, MS, MSPH
Research Professor, Thomas Jefferson University, Philadelphia, PA, USA

Stephanie Manson, PhD
Senior Director, HEOR Excellence, Novartis, East Hanover, NJ, USA

Robert Brett McQueen, PhD, MS
Assistant Professor, Center for Pharmaceutical Outcomes Research (CePOR), Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

Homero Monsanto, PhD, MS
Health Economics and Outcomes Researcher, Guaynabo, Puerto Rico

Michelle Mujoomdar, PhD
Director, Strategic Policy Branch, Health Canada, Ottawa, ON, Canada

Tarlan Namvar, PharmD, MS
Health Economics and Outcomes Research Fellow, Adjunct Faculty, Piscataway, NJ, USA

Soumana Chamoun Nasser, BS Pharm, PharmD, MS
Clinical Associate Professor, Chair, Department of Pharmacy Practice, Department of Pharmacy Practice, Lebanese American University, Byblos, Lebanon

Maciej Niewada, MD
President, ISPOR Poland Regional Chapter Office; Professor, Department of Clinical & Experimental Pharmacology of Medical University of Warsaw; HEALTHQUEST Company, Warsaw, Poland

William Padula, PhD
Assistant Professor of Pharmaceutical and Health Economics, Schaeffer Center for Health Policy and Economics, USC School of Pharmacy, Los Angeles, CA, USA

Bray Patrick-Lake, MFS
Director of Strategic Partnerships, Evidation Health, San Mateo, CA, USA

Casey Quinn, MPhil, PhD
Senior Advisor for Patient-Centered Economic Outcomes, Patient-Centered Outcomes Research Institute (PCORI), Washington, DC, USA

Alfonso J. Rodríguez-Morales, MSc, ScD, MD
Professor of Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia

Claire Rothery, MSc, MSci, PhD, MPhil
Senior Research Fellow, Centre for Health Economics, University of York, York, England, UK

Asrul Akmal Shafie, PhD
Associate Professor, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

Julia Slejko, PhD
Associate Professor of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, USA

Mehtap Tatar, BSc, MSc, PhD
Director, Polar Health Economics and Policy Consultancy, Ankara, Turkey


Xiao Xu, PhD, MA
Associate Professor, Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine; Faculty member of the Yale Center for Outcomes Research & Evaluation (CORE) and Yale Cancer Outcomes, Public Policy and Effectiveness Research Center (COPPER), New Haven, CT, USA